ALLMedicine™ Focal Segmental Glomerulosclerosis Center
Research & Reviews 836 results
https://doi.org/10.1681/ASN.2021101396
Journal of the American Society of Nephrology : JASN; Zee J, Liu Q et. al.
May 18th, 2022 - Heterogeneity in disease course and treatment response among patients with MCD/FSGS necessitates a granular evaluation of kidney tissue features. This study aimed to identify histologic and ultrastructural descriptors of structural changes most pr...
https://clinicaltrials.gov/ct2/show/NCT00001392
May 13th, 2022 - The present protocol seeks to advance our understanding of sclerosing glomerular and tubulointerstitial kidney diseases, including but not limited to variants of focal segmental glomerulosclerosis (FSGS) and chronic kidney disease of unknown etiol...
https://clinicaltrials.gov/ct2/show/NCT05003986
May 11th, 2022 - This is a multicenter, open-label, 108-week study of sparsentan in approximately 57 pediatric subjects aged ≥1 year to <18 years with selected proteinuric glomerular diseases, divided into 2 populations, defined as follows: Population 1: Subjects ...
https://doi.org/10.1002/jca.21985
Journal of Clinical Apheresis; Dirim AB, Demir E et. al.
May 11th, 2022 - Primary focal segmental glomerulosclerosis (FSGS) treatment is based on immunosuppressive therapies. Since refractory disease is common, alternative methods are emerging. One of these methods is plasmapheresis with intravenous cyclosporine and cor...
https://doi.org/10.1016/j.kint.2022.03.029
Kidney International; Kökény G, Németh Á et. al.
May 6th, 2022 - Patients with chronic kidney disease and experimental animal models of kidney fibrosis manifest diverse progression rates. Genetic susceptibility may contribute to this diversity, but the causes remain largely unknown. We have previously described...
Guidelines 2 results
https://doi.org/10.1016/j.kint.2021.05.015
Kidney International; Rovin BH, Adler SG et. al.
Sep 25th, 2021 - The Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Management of Glomerular Diseases is an update to the KDIGO 2012 guideline. The aim is to assist clinicians caring for individuals with glomerulonephritis (G...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983378
Kidney International; Swanepoel CR, Atta MG et. al.
Feb 6th, 2018 - HIV-positive individuals are at increased risk for kidney disease, including HIV-associated nephropathy, noncollapsing focal segmental glomerulosclerosis, immune-complex kidney disease, and comorbid kidney disease, as well as kidney injury resulti...
Drugs 4 results see all →
Clinicaltrials.gov 22 results
https://clinicaltrials.gov/ct2/show/NCT00001392
May 13th, 2022 - The present protocol seeks to advance our understanding of sclerosing glomerular and tubulointerstitial kidney diseases, including but not limited to variants of focal segmental glomerulosclerosis (FSGS) and chronic kidney disease of unknown etiol...
https://clinicaltrials.gov/ct2/show/NCT05003986
May 11th, 2022 - This is a multicenter, open-label, 108-week study of sparsentan in approximately 57 pediatric subjects aged ≥1 year to <18 years with selected proteinuric glomerular diseases, divided into 2 populations, defined as follows: Population 1: Subjects ...
https://clinicaltrials.gov/ct2/show/NCT05213624
May 3rd, 2022 - This study is open to adults with a type of kidney disease called primary focal segmental glomerulosclerosis (FSGS). The purpose of this study is to find out whether a medicine called BI 764198 improves the health of the kidneys in people with FSG...
https://clinicaltrials.gov/ct2/show/NCT03448692
May 2nd, 2022 - The purpose of this Phase 2 adaptive study is to evaluate the efficacy, safety, tolerability and pharmacokinetics of PF-06730512 following multiple intravenous infusions in adult subjects with FSGS.
https://clinicaltrials.gov/ct2/show/NCT05301829
Mar 31st, 2022 - Thrombin generation test will be performed prospectively in nephrotic patients with various diseases (Minimal Change Disease (MCD), Malignant Nephrosclerosis (MN), Focal Segmental GlomeruloSclerosis (FSGS), diabetic glomerulopathy…) at diagnosis, ...
News 27 results
https://www.medscape.com/viewarticle/954056
Jul 1st, 2021 - NEW YORK (Reuters Health) - Adults with primary nephrotic syndrome (NS) had close to a 20 times greater risk of developing kidney failure and higher risks of several cardiovascular diseases and death compared to those without NS in a large analysi...
https://www.medscape.com/viewarticle/939052
Oct 13th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Admission levels of a specific protein predict the development of acute kidney injury (AKI) as well as the need for dialysis in patients hospitali...
https://www.mdedge.com/rheumatology/article/228758/lupus-connective-tissue-diseases/late-onset-neutropenia-more-common
Steve Cimino
Sep 18th, 2020 - A new study has found that late-onset neutropenia is a notably common and occasionally serious occurrence in rituximab-treated patients with autoimmune diseases. Dr.
https://www.reuters.com/article/brief-vifor-pharma-vfmcrp-and-chemocentr/brief-vifor-pharma-vfmcrp-and-chemocentryx-announce-topline-data-from-phase-ii-lumina-1-trial-of-ccx140-in-focal-segmental-glomerulosclerosis-idUSASN0006W6
May 18th, 2020 - May 18 (Reuters) - VIFOR PHARMA AG: * VFMCRP AND CHEMOCENTRYX ANNOUNCE TOPLINE DATA FROM PHASE-II LUMINA-1 TRIAL OF CCX140 IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) Source text for Eikon: Further company coverage: (Gdansk Newsroom)
https://www.medscape.com/viewarticle/904069
Feb 24th, 2020 - First-line Therapy for Nephrotic Syndrome: A Comparison Idiopathic nephrotic syndrome is the most common disorder of glomerular function in pediatrics.[1] Approximately 40% of children diagnosed with idiopathic nephrotic syndrome will have a relap...